CONTEXT THERAPEUTICS
Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat hormone-responsive cancers. Context’s lead program is Apristor (Onapristone XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) metastatic breast and ovarian cancers. In addition, Context is advancing CTX-030916, a potential best-in-class oral antiprogestin for the treatment of uterine fibroids and endometriosis, and a discovery-stage program targeting Sigma1.
CONTEXT THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.contexttherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
31.25 M USD
Technology used in webpage:
Viewport Meta Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Euro Organization Schema
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Allero Therapeutics
Allero Therapeutics is a biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Chromis Therapeutics
Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company
Cloudbreak Therapeutics
Cloudbreak Therapeutics is a clinical stage biotechnology company
Destiny Pharma
Destiny Pharma Ltd., a clinical stage pharmaceutical company
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
HighTide Therapeutics
HighTide Therapeutics is a global clinical-stage biopharmaceutical company.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
Metera Pharmaceuticals
Metera Pharmaceuticals is a preclinical stage biotechnology company.
MetrioPharm
MetrioPharm is a clinical stage pharmaceutical development company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Aralez Pharmaceuticals
Aralez Pharmaceuticals is a global specialty pharmaceutical company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Soleno Therapeutics
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Vyriad
Vyriad is a clinical stage biopharmaceutical company.
YS Biopharma
YS Biopharma is a global, fully integrated bio-pharmaceutical company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
ZSX Medical
ZSX Medical, LLC, is a pre-clinical stage medical device company.
Current Employees Featured
Martin Lehr CEO and Director @ Context Therapeutics
CEO and Director
2015-01-01
Deepak Lala Chief Technology Officer @ Context Therapeutics
Chief Technology Officer
Founder
Stock Details
Official Site Inspections
http://www.contexttherapeutics.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.63 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Context Therapeutics"
Context Therapeutics
Context Therapeutics is advancing medicines for female cancers. Context is dedicated to developing the next generation of T cell engaging (TCE) bispecific antibody therapies to treat …See details»
Team Bios - Context Therapeutics
She is responsible for all aspects of GMP/GCP/GLP quality for the organization. Erin has more than 15 years’ experience in the pharmaceutical industry in various analytical and quality …See details»
Context Therapeutics - LinkedIn
Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors. Most recently, Mr. Pasternak served as Executive Vice President, Chief Strategy Officer at Horizon …See details»
Context Therapeutics Appoints Andy Pasternak as Chairman of the …
4 days ago For more information, please visit www.contexttherapeutics.com or follow the Company on X (formerly Twitter) and LinkedIn. Forward-looking Statements This press …See details»
Context Therapeutics - Crunchbase Company Profile & Funding
Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat hormone-responsive cancers. Context’s lead program is Apristor …See details»
Committee Composition - Context Therapeutics Inc.
The Investor Relations website contains information about Context Therapeutics Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Context Therapeutics
Dec 19, 2024 The company has grown from a small research and development company to an established, global biopharmaceutical organization. The company is committed to delivering …See details»
Context Therapeutics® Highlights 2023 Corporate Priorities and …
Jan 4, 2023 Context is headquartered in Philadelphia. For more information, please visit www.contexttherapeutics.com or follow the Company on Twitter and LinkedIn. References [1] …See details»
MaryBeth LeRose — Context Therapeutics
Jan 20, 2021 MaryBeth LeRose is currently an Associate Director of Clinical Operations at Context Therapeutics. She is an accomplished clinical project manager with over eight years …See details»
Context Therapeutics - Craft
May 8, 2024 Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating medicines treating hormone-responsive cancers. It develops Onapristone ER …See details»
Context Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
For more information, please visit www.contexttherapeutics.com or follow the Company on X (formerly Twitter) and LinkedIn. ... The statistics for drugs in the Pipeline is the current …See details»
Context Therapeutics® Strengthens Research & Development Team
Jan 5, 2022 For more information, visit www.contexttherapeutics.com. Forward-looking Statements This press release contains “forward-looking statements” that involve substantial …See details»
Context Therapeutics - Overview, News & Similar companies
May 8, 2024 www.contexttherapeutics.com. Revenue $22.2 Million. Stock Symbol CNTX. Industry Business Services General Business Services . Most Recent Scoops. May 9 2024. …See details»
Context Therapeutics Inc. Appoints Andy Pasternak as Chairman
3 days ago Andy Pasternak's appointment as Chairman brings decades of global pharmaceutical leadership experience, enhancing the company's strategic capabilities. This …See details»
Context Therapeutics Expands Board of Directors
Mar 22, 2021 ONA-XR is a novel, first-in-class complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women’s cancers. Context is …See details»
Context Therapeutics Company Overview, Contact Details
May 2, 2024 For more information, visit www.contexttherapeutics.com. Sign up for free to view info. Email Format Employee directory . Company Overview. Headquarters 2001 Market …See details»
Patients — Context Therapeutics
Summary of Context Therapeutics clinical trials. Enrollment in one of our clinical trials is our primary method for providing patients with access to our investigational drugs prior to their …See details»
Context Therapeutics to Participate in Upcoming Investor …
Oct 23, 2024 For more information, please visit www.contexttherapeutics.com or follow the Company on X (formerly Twitter) and LinkedIn. Forward-looking Statements This press …See details»
Context Therapeutics, Inc. (Context Therapeutics, Inc.) - 药物管线_ …
For more information, please visit www.contexttherapeutics.com or follow the Company on X (formerly Twitter) and LinkedIn. Forward-looking StatementsThis press release contains …See details»
Contact — Context Therapeutics
Context Therapeutics. 2001 Market Street Suite 3915, Unit 15 Philadelphia, PA 19103. P: 267.225.7416See details»